The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

26 Sep 2022 14:40

RNS Number : 6775A
Honeycomb Investment Trust PLC
26 September 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

THIS IS AN ANNOUNCEMENT AND NOT A PROSPECTUS OR EQUIVALENT DOCUMENT. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM PART OF, AND SHOULD NOT BE CONSTRUED AS, ANY OFFER, INVITATION OR RECOMMENDATION TO PURCHASE, SELL OR SUBSCRIBE FOR ANY SECURITIES IN ANY JURISDICTION AND NEITHER THE ISSUE OF THE INFORMATION NOR ANYTHING CONTAINED HEREIN SHALL FORM THE BASIS OF OR BE RELIED UPON IN CONNECTION WITH, OR ACT AS AN INDUCEMENT TO ENTER INTO, ANY INVESTMENT ACTIVITY

 

FOR IMMEDIATE RELEASE

26 September 2022

Honeycomb Investment Trust plc ("Honeycomb")

Publication of Prospectus

Honeycomb is pleased to confirm that the Financial Conduct Authority (the "FCA") has today approved Honeycomb's prospectus (the "Prospectus") in relation to the proposed combination of Honeycomb with Pollen Street Capital Holdings Limited, as announced by Honeycomb on 15 February 2022 (the "Combination"). The Prospectus contains further information on the Combination and the application for admission of the Consideration Shares to the premium listing segment of the Official List of the FCA and to trading on the main market for listed securities of the London Stock Exchange.

As part of the Combination, 29,472,663 Consideration Shares will be issued to the Pollen Street Shareholders. An application has been made for the admission of the Consideration Shares to the premium listing segment of the Official List of the FCA and to trading on the main market for listed securities of the London Stock Exchange ("Admission").

Admission is expected to occur at 08.00am on 30 September 2022. The remaining conditions to Completion under the SPA will be satisfied once Admission has been approved by each of the FCA and the London Stock Exchange. Honeycomb subsequently anticipates that Completion will also occur on 30 September 2022.

Immediately following Admission, Honeycomb will have 68,922,582 ordinary shares of £0.01 each in issue of which 4,712,985 ordinary shares are currently held by Honeycomb as treasury shares, and therefore the total voting rights will be 64,209,597. This figure may be used by Shareholders as the denominator for the calculations by which they may determine whether or not they are required to notify their interest in, or a change in their interest in, the share capital of Honeycomb under the FCA's Disclosure and Transparency Rules.

The Prospectus has been submitted to the FCA's National Storage Mechanism (the "NSM") and will be available for inspection on the NSM's website at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The Prospectus will also be available on Honeycomb's website at https://www.honeycombplc.com/.

Terms defined in the Prospectus shall have the same meaning in this announcement.

Enquiries:

Cenkos - Financial Adviser, Sponsor and Joint Broker to Honeycomb

Tunga Chigovanyika

Daniel BalabanoffJustin Zawoda Martin

+44 20 7397 8900

 

BofA Securities - Financial Adviser to Honeycomb Geoff Iles

Oliver Elias

Charles Pitt Ford

+44 20 7628 1000

Liberum - Joint Broker

Chris Clarke

+44 20 3100 2000

 

FGS Global - Communications Adviser

Chris Sibbald

+44 20 7251 3801

 

About Honeycomb

Honeycomb is a UK-listed closed ended investment trust dedicated to providing investors with access to asset backed lending opportunities, with potential to generate high income returns, together with strong capital preservation.

About Pollen Street

Pollen Street was founded in 2013 and is an independent, alternative investment management company dedicated to investing in the financial and business services sectors. Pollen Street has extensive experience investing in both credit and private equity strategies and has a strong and consistent track record of delivering top tier returns. A wholly owned subsidiary of Pollen Street serves as Honeycomb's investment manager.

Additional information

Merrill Lynch International ("BofA Securities"), which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the FCA and the PRA in the United Kingdom, is acting as financial adviser exclusively for Honeycomb and for no one else and will not be responsible to anyone other than Honeycomb for providing the protections afforded to its clients or for providing advice in relation to the matters referred to in this announcement. Neither BofA Securities, nor any of its affiliates, owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of BofA Securities in connection with this announcement, the Prospectus, or any statement contained herein or otherwise.

Cenkos Securities plc ("Cenkos"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively as financial adviser and sponsor for Honeycomb and for no one else in connection with the Combination and Admission and will not be responsible to anyone other than Honeycomb for providing the protections afforded to its clients or for providing advice in relation to the matters referred to in this announcement or any other arrangement referred to, or information contained in, the Prospectus. Neither Cenkos, nor any of its affiliates, owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Cenkos in connection with this announcement, the Prospectus, or any statement contained herein or otherwise.

Liberum Capital Limited ("Liberum") is authorised and regulated in the United Kingdom by the FCA and is acting exclusively for Honeycomb and no-one else in connection with the proposed Combination and will not be responsible to anyone other than the Honeycomb for providing the protections afforded to the clients of Liberum, as applicable, or for affording advice in relation to the contents of the announcement, the Prospectus, or any matters referred to therein. Nothing in this paragraph shall serve to exclude or limit any responsibilities Liberum may have under the Financial Services and Markets Act 2000 or the regulatory regime established thereunder.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIBXGDCCXDDGDL
Date   Source Headline
1st Nov 20213:58 pmRNSDirector Declaration
28th Oct 202110:42 amRNSNAV and Monthly Update August 2021 - Replacement
28th Oct 20217:00 amRNSNAV and Monthly Update September 2021
20th Oct 202111:57 amRNSHolding(s) in Company
1st Oct 20217:05 amRNSDirector Declaration
29th Sep 20217:00 amRNSNAV and Monthly Update September 2021
15th Sep 20217:00 amRNSHalf-year Report
8th Sep 20214:53 pmRNSNotification of Board Committee Changes
8th Sep 20217:00 amRNSDividend Declaration
7th Sep 20217:00 amRNSNAV and Monthly Update - July 2021
28th Jul 20217:00 amRNSNAV and Monthly Update - June 2021
29th Jun 20217:00 amRNSNAV and Monthly Update - May 2021
8th Jun 20215:15 pmRNSResult of AGM
28th May 20219:39 amRNSDirector/PDMR Shareholding
27th May 20217:00 amRNSNAV and Monthly Update - April 2021
14th May 202111:54 amRNSDirector/PDMR Shareholding
10th May 20214:53 pmRNSPosting of Annual Report and Notice of AGM
30th Apr 20217:02 amRNSAnnual Report and Audited Financial Statements
30th Apr 20217:01 amRNSDividend Declaration
30th Apr 20217:00 amRNSNAV and Monthly Update - March 2021
1st Apr 20217:00 amRNSNAV and Monthly Update - February 2021
4th Mar 20217:00 amRNSNAV and Monthly Update - January 2021
26th Feb 20217:00 amRNSDividend Declaration
25th Feb 20214:14 pmRNSBoard Committee Changes & SID Appointment
12th Feb 20217:00 amRNSNAV and Monthly Update - December 2020
12th Jan 20211:43 pmRNSHolding(s) in Company
12th Jan 20211:40 pmRNSHolding(s) in Company
12th Jan 202111:38 amRNSHolding(s) in Company
7th Jan 20217:00 amRNSNAV and Monthly Update - November 2020
29th Dec 202012:22 pmRNSDirectorate Change
18th Dec 202010:21 amRNSKepler Trust Intelligence: New Research
1st Dec 20207:01 amRNSMonthly Update – October 2020
1st Dec 20207:00 amRNSNet Asset Value(s)
20th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
19th Nov 20207:00 amRNSDividend Declaration
19th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
18th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
16th Nov 20204:54 pmRNSHolding(s) in Company
13th Nov 202011:11 amRNSDirector/PDMR Shareholding
13th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
12th Nov 20209:50 amRNSHolding(s) in Company
12th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
11th Nov 20207:00 amRNSShare Buy-Back Programme
6th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
5th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
4th Nov 20207:01 amRNSMonthly Update - September 2020
4th Nov 20207:00 amRNSNet Asset Value(s)
4th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
3rd Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
2nd Nov 20205:01 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.